Congenital Transmission of Trypanosoma cruzi: A Review About the Interactions Between the Parasite, the Placenta, the Maternal and the Fetal/Neonatal Immune Responses
- PMID: 31474955
- PMCID: PMC6702454
- DOI: 10.3389/fmicb.2019.01854
Congenital Transmission of Trypanosoma cruzi: A Review About the Interactions Between the Parasite, the Placenta, the Maternal and the Fetal/Neonatal Immune Responses
Abstract
Chagas disease (CD), caused by the protozoan parasite Trypanosoma cruzi, is considered a neglected tropical disease by the World Health Organization. Congenital transmission of CD is an increasingly relevant public health problem. It progressively becomes the main transmission route over others and can occur in both endemic and non-endemic countries. Though most congenitally infected newborns are asymptomatic at birth, they display higher frequencies of prematurity, low birth weight, and lower Apgar scores compared to uninfected ones, and some suffer from severe symptoms. If not diagnosed and treated, infected newborns are at risk of developing disabling and life-threatening chronic pathologies later in life. The success or failure of congenital transmission depends on interactions between the parasite, the placenta, the mother, and the fetus. We review and discuss here the current knowledge about these parameters, including parasite virulence factors such as exovesicles, placental tropism, potential placental defense mechanisms, the placental transcriptome of infected women, gene polymorphism, and the maternal and fetal/neonatal immune responses, that might modulate the risk of T. cruzi congenital transmission.
Keywords: Trypanosoma cruzi; congenital chagas disease; infection; maternal-fetal interactions; placenta.
Figures

Similar articles
-
Congenital Chagas disease as an ecological model of interactions between Trypanosoma cruzi parasites, pregnant women, placenta and fetuses.Acta Trop. 2015 Nov;151:103-15. doi: 10.1016/j.actatropica.2015.07.016. Epub 2015 Aug 17. Acta Trop. 2015. PMID: 26293886
-
Is Antibody-Dependent Enhancement of Trypanosoma cruzi Infection Contributing to Congenital/Neonatal Chagas Disease?Front Immunol. 2021 Sep 10;12:723516. doi: 10.3389/fimmu.2021.723516. eCollection 2021. Front Immunol. 2021. PMID: 34566981 Free PMC article.
-
Trypanosoma cruzi Infection at the Maternal-Fetal Interface: Implications of Parasite Load in the Congenital Transmission and Challenges in the Diagnosis of Infected Newborns.Front Microbiol. 2019 Jun 7;10:1250. doi: 10.3389/fmicb.2019.01250. eCollection 2019. Front Microbiol. 2019. PMID: 31231337 Free PMC article. Review.
-
The immune response against Trypanosoma cruzi in the human placenta.Emerg Top Life Sci. 2017 Dec 22;1(6):573-577. doi: 10.1042/ETLS20170115. Emerg Top Life Sci. 2017. PMID: 33525837
-
Animal Models of Trypanosoma cruzi Congenital Transmission.Pathogens. 2022 Oct 11;11(10):1172. doi: 10.3390/pathogens11101172. Pathogens. 2022. PMID: 36297229 Free PMC article. Review.
Cited by
-
Ex Vivo Infection of Human Placental Explants by Trypanosoma cruzi Reveals a microRNA Profile Similar to That Seen in Trophoblast Differentiation.Pathogens. 2022 Mar 16;11(3):361. doi: 10.3390/pathogens11030361. Pathogens. 2022. PMID: 35335686 Free PMC article.
-
Trypanosoma cruzi-derived exovesicles contribute to parasite infection, tissue damage, and apoptotic cell death during ex vivo infection of human placental explants.Front Cell Infect Microbiol. 2024 Oct 14;14:1437339. doi: 10.3389/fcimb.2024.1437339. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39469456 Free PMC article.
-
Chagas Disease in Europe.Trop Med Infect Dis. 2023 Dec 1;8(12):513. doi: 10.3390/tropicalmed8120513. Trop Med Infect Dis. 2023. PMID: 38133445 Free PMC article. Review.
-
Congenital transmission of Mexican strains of Trypanosoma cruzi TcIa: interaction between parasite and human placental explants.Parasitology. 2022 Mar;149(3):418-426. doi: 10.1017/S0031182021002018. Epub 2021 Nov 24. Parasitology. 2022. PMID: 34814960 Free PMC article.
-
Trypanosoma cruzi P21 recombinant protein modulates Toxoplasma gondii infection in different experimental models of the human maternal-fetal interface.Front Immunol. 2023 Oct 16;14:1243480. doi: 10.3389/fimmu.2023.1243480. eCollection 2023. Front Immunol. 2023. PMID: 37915581 Free PMC article.
References
-
- Almeida I. C., Gazzinelli R. T. (2001). Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J. Leukoc. Biol. 70 467–477. - PubMed
Publication types
LinkOut - more resources
Full Text Sources